Develops the Science Eye, a retinal implant to restore vision, and other neurotechnology platforms led by former Neuralink president.

Vision & Sensory Prosthetics · Series C $230M

Vision & Sensory Prosthetics

Series C

$230M

HQ

Offers EEG-based brain-sensing headbands for education, focus training, prosthetic control, and wellness applications.

Non-Invasive Consumer EEG · Series B+ $286M

Non-Invasive Consumer EEG

Series B+

$286M

HQ

OpenAI-backed research lab building non-invasive, high-bandwidth brain-computer interfaces that read and write to neurons using molecules and ultrasound instead of implanted electrodes.

Non-Invasive Neuroimaging · Seed $252M

Non-Invasive Neuroimaging

Seed

$252M

HQ

Delivers a motor neuroprosthesis via the jugular vein into brain blood vessels, avoiding open brain surgery.

Endovascular BCI · Series D $200M

Endovascular BCI

Series D

$200M

HQ

Develops the Evoke closed-loop spinal cord stimulation system, the first SCS device that senses the spinal cord's ECAP response and adjusts therapy on every pulse.

Spinal & Peripheral Interfaces · IPO $150M

Spinal & Peripheral Interfaces

IPO

$150M

HQ

Develops soft, flexible neural electrode arrays designed to minimize scarring and improve long-term biocompatibility in brain implants.

Next-Gen Electrodes & Materials · Series A $55M

Next-Gen Electrodes & Materials

Series A

$55M

HQ

Embeds EEG sensors into everyday headphones to track focus, attention, and cognitive state for productivity and wellness.

Non-Invasive Consumer EEG · Series A $35M

Non-Invasive Consumer EEG

Series A

$35M

HQ

Develops in-ear EEG biosensors for continuous brain activity monitoring in wearable form-factors.

Non-Invasive Consumer EEG · Series A $16M

Non-Invasive Consumer EEG

Series A

$16M

HQ

Designs miniaturized, wireless neural implants with on-board AI processing to decode brain signals locally and reduce data bandwidth requirements.

Invasive Cortical Implants · Seed $10M

Invasive Cortical Implants

Seed

$10M

HQ

Develops high-bandwidth implantable brain-machine interfaces with thousands of electrode channels for paralysis and neurological conditions.

Invasive Cortical Implants · Series E $650M

Invasive Cortical Implants

Series E

$650M

HQ

Develops a flexible, thin-film electrode array placed on the brain surface to enable high-resolution neural recording with minimally-invasive placement.

Invasive Cortical Implants · Series C $102M

Invasive Cortical Implants

Series C

$102M

HQ

Provides virtual-reality and brain-sensing platforms for stroke rehabilitation and neurological recovery, combining VR with EEG-based neurofeedback.

Non-Invasive Clinical EEG · Growth $125M

Non-Invasive Clinical EEG

Growth

$125M

HQ

Engineers graphene-based neural interfaces for high-resolution, biocompatible brain recording and stimulation.

Manufactures the Utah Array and other electrode systems used in academic BCI research and clinical trials for over a decade.

Invasive Cortical Implants · Acquired $200M

Invasive Cortical Implants

Acquired

$200M

HQ

Develops spinal cord stimulation platforms to restore movement and function in patients with spinal cord injury.

Spinal & Peripheral Interfaces · IPO $89.6M

Spinal & Peripheral Interfaces

IPO

$89.6M

HQ

Offers a rapid-deployment EEG system with AI-powered seizure detection for emergency and ICU settings.

Non-Invasive Clinical EEG · Market cap $736.1M

Non-Invasive Clinical EEG

Market cap

$736.1M

HQ

Develops peripheral nerve interfaces and implantable devices for prosthetic control and sensory feedback.

Spinal & Peripheral Interfaces · Series A $19M

Spinal & Peripheral Interfaces

Series A

$19M

HQ

Develops magnetoelectric neural stimulation technology for non-invasive, deep-brain modulation targeting psychiatric and neurological disorders.

Neuromodulation & Stimulation · Series A $18.8M

Neuromodulation & Stimulation

Series A

$18.8M

HQ

Forest Neurotech is developing an ultrasound-based brain-computer interface for whole-brain imaging and neuromodulation, aiming to read from and stimulate deep brain structures less invasively than electrode implants.

Next-Gen Electrodes & Materials · Series A $14M

Next-Gen Electrodes & Materials

Series A

$14M

HQ

Builds a wearable headband that uses real-time EEG and acoustic stimulation to accelerate sleep onset and improve sleep quality.

Non-Invasive Consumer EEG · Seed $12M

Non-Invasive Consumer EEG

Seed

$12M

HQ

Produces wearable time-domain functional near-infrared spectroscopy headsets for brain activity measurement in research and commercial settings.

Non-Invasive Neuroimaging · Series C $53M

Non-Invasive Neuroimaging

Series C

$53M

HQ

Builds very-high-density cortical implants targeting tens of thousands of electrodes for speech and communication restoration.

Invasive Cortical Implants · Series A $33M

Invasive Cortical Implants

Series A

$33M

HQ

Builds the Crown, a wearable EEG headset with real-time brain-computer interface software for focus, meditation, and app control.

Non-Invasive Consumer EEG · Series A $5.0M

Non-Invasive Consumer EEG

Series A

$5.0M

HQ

MIT Media Lab spinout building the MouthPad^, a custom-fit intraoral touchpad that lets people control phones and computers hands-free with tongue and head gestures.

Assistive BCI Devices · Seed $4M

Assistive BCI Devices

Seed

$4M

HQ

Develops non-invasive transcranial electrical stimulation and EEG systems for research and clinical applications in epilepsy and neurorehabilitation.

Produces augmented-reality headsets with integrated EEG for non-verbal communication and assistive technology for patients with speech and motor impairments.

Assistive BCI Devices · Seed $1.8M

Assistive BCI Devices

Seed

$1.8M

HQ

Provides AI-powered software that interprets brain and body signals from wearable sensors for emotional and cognitive state detection.

Non-Invasive Consumer EEG · Series A $10M

Non-Invasive Consumer EEG

Series A

$10M

HQ

Produces a transcranial direct current stimulation headset for at-home treatment of depression, combined with behavioral therapy.

Neuromodulation & Stimulation · Series A $9.3M

Neuromodulation & Stimulation

Series A

$9.3M

HQ

Develops the RNS System, a responsive neurostimulation device that detects and treats epileptic seizures in real time.

Neuromodulation & Stimulation · Market cap $572.1M

Neuromodulation & Stimulation

Market cap

$572.1M

HQ

Manufactures wireless EEG headsets and software for research, education, and consumer brain-computer interface applications.

Non-Invasive Consumer EEG · Seed $3.9M

Non-Invasive Consumer EEG

Seed

$3.9M

HQ

Provides open-source EEG, EMG, and ECG biosensing hardware and software for researchers and developers building BCI applications.

Non-Invasive Consumer EEG · Seed $1.8M

Non-Invasive Consumer EEG

Seed

$1.8M

HQ

Develops smart glasses with integrated EEG sensors for cognitive state monitoring and accessibility applications.

Non-Invasive Consumer EEG · Seed

Non-Invasive Consumer EEG

Seed

—

HQ

Reads and modulates the vagus nerve to treat chronic inflammatory diseases using implantable neural interfaces.

Spinal & Peripheral Interfaces · Series A

Spinal & Peripheral Interfaces

Series A

—

HQ

Joint venture between GSK and Verily developing bioelectronic medicines that modulate peripheral nerves for chronic disease treatment.

Spinal & Peripheral Interfaces · Series A

Spinal & Peripheral Interfaces

Series A

—

HQ

Manufactures research-grade neural recording systems and microelectrode arrays for preclinical and clinical BCI applications.

Invasive Cortical Implants

Invasive Cortical Implants

—

—

HQ

Research organization developing NeuroLife, a BCI system that bypasses spinal cord injury to restore hand and arm movement via cortical recording and muscle stimulation.

Invasive Cortical Implants

Invasive Cortical Implants

—

—

HQ

Manufactures clinical-grade EEG and BCI systems for research, rehabilitation, and assistive technology applications.

Provides spinal cord stimulation and deep brain stimulation devices for chronic pain, Parkinson's disease, and essential tremor.

Neuromodulation & Stimulation · Market cap $66.6B

Neuromodulation & Stimulation

Market cap

$66.6B

HQ

Manufactures deep brain stimulation, spinal cord stimulation, and other implantable neuromodulation devices for Parkinson's, pain, and movement disorders.

Offers spinal cord stimulation, dorsal root ganglion stimulation, and deep brain stimulation systems for chronic pain and movement disorders.

Neuromodulation & Stimulation · Market cap $165.8B

Neuromodulation & Stimulation

Market cap

$165.8B

HQ